Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Why Zero Based Budgeting Is Popular explains its straightforward approach and strong results for disciplined spenders.
22,446 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Nebius stock surged today as a strategic Nvidia partnership added momentum to an AI cloud story. This article breaks ...
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
A high-profile case shows how documents and timing can influence money choices. This article breaks down the lessons ...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A wave of upgrades is reshaping Near Protocol. Privacy features, AI-ready smart contracts, and scaling improvements c...
Anterix stock surged 140% as a major investor disclosed a multi-million dollar buy. This article breaks down the driv...
An elderly shopper nearly handed over $18,000 in cash to a scam caller. A vigilant store clerk stepped in, proving on...
As Disney readies Toy Story 5, investors wonder if this beloved IP can spark a broader upswing. This piece breaks dow...
Retail investors often wonder if congressional trades offer investing clues. This guide explains what "members congre...
I run my investments on my own, but I still reserve a passive sleeve to reduce risk and simplify life. This is how I ...
CoreWeave’s latest trading session highlighted the tension between high-growth AI clouds and the realities of funding...